InflaRx intends to engage with EMA regarding both vilobelimab and izicopan to evaluate the regulatory path to approval in ANCA-associated ...
Spread the love“`html The AI industry news this week has been nothing short of electrifying, with major developments that have the potential to reshape our understanding and interaction with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results